The accumulation of1H MR-visible lipid in human glioma cells is independent of the cell cycle

International Journal of Oncology

Volumn 11, Issue 3, 1997, Pages 543-550

  Delikatny, Edward J ^a   Jeitner, Thomas M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WADSWORTH CENTER   (United States)

Author keywords

Brain tumours; Cell cycle; Cysteamine; Desferrioxamine; Iron chelators; Lipid; NMR

Indexed keywords

DEFEROXAMINE; LIPID; MERCAPTAMINE; RAZOXANE;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; LIPID METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

EID: 0030797234     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Negendank W: Studies of human tumours by MRS: a review. NMR in Biomed 5: 303-324, 1992.
2. 31P MRS of experimental tumours. NMR in Biomed 6: 345-365, 1993.
3. 1H magnetic resonance spectroscopy. Int J Cancer 59: 248-261, 1994.
4. Delikatny EJ, Lander CM, Jeitner TM, Hancock R and Mountford CE: Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response. Int J Cancer 65: 238-245, 1996.
5. Mountford CE, Grossman G, Reid G and Fox RM: Characterization of transformed cells and tumours by proton nuclear magnetic resonance spectroscopy. Cancer Res 42: 2270-2276, 1982.
6. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn Reson Med 29: 546-550, 1993.
7. Delikatny EJ, Roman SK, Hancock R, Jeitner TM, Lander CM, Rideout DC and Mountford CE: Tetraphenylphosphonium chloride induced MR-visible lipid accumulation in a malignant human breast cell line. Int J Cancer 67: 72-79, 1996.
8. Le Moyec L, Tatoud R, Degeorges A, Calabresse C, Bauza G, Eugène M and Calvo F: Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukaemia cell line. Cancer Res 56: 3461-3467, 1996.
9. Dingley AJ, King NJC and King GF: An NMR investigation of the changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes. Biochemistry 31: 9098-9106, 1992.
10. 1H Magnetic resonance spectroscopy of primary human and murine cells of the myeloid lineage. ImmunoMethods 4: 188-198, 1994.
11. Mountford CE and Mackinnon WB: Proton magnetic resonance spectroscopy of lymphocytes: An historical perspective. ImmunoMethods 4: 98-112, 1994.
12. May GL, Sztelma K, Paul ML and Sorrell TC: Proton magnetic resonance spectroscopy of polymorphonuclear leukocytes from patients with serious bacterial infections. J Infect Diseases 168: 386-392, 1993.
13. 1H MR spectrum in murine T-cells and B-cells occurs in G1 phase of cell cycle. Magn Reson Med 16: 1-8, 1990.
14. 1H-NMR visible neutral lipids in activated T lymphocytes: relationship to phosphatidylcholine cycling. Biochim Biophys Acta 1303: 215-221, 1996.
15. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR in Biomed 7: 149-155, 1994.
16. 1H MR spectroscopy. NMR in Biomed 7: 172-180, 1994.
17. 31P NMR spectroscopy. NMR Biomed 8: 149-158, 1995.
18. 1H NMR studies of membrane changes during the activation of primary T-lymphocytes. ImmunoMethods 4: 127-138, 1994.
19. Jeitner TM, Kneale CL, Christopherson RI and Hunt NH: Thiolbearing compounds selectively inhibit protein kinase C-dependent oxidative events and proliferation in human T cells. Biochim Biophys Acta 1223: 15-22, 1994.
20. Goldstone SD, Fragonas JC, Jeitner TM and Hunt NH: Transcription factors as targets for oxidative signalling during lymphocyte activation. Biochim Biophys Acta 1263: 114-122, 1995.
21. Jeitner TM and Renton FJ: Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine. Cancer Lett 103: 85-90, 1996.
22. Renton FJ and Jeitner TM: Cell cycle-dependent inhibition of the proliferation of human neural tumour cell lines by iron chelators. Biochem Pharmacol 51: 1553-1561, 1996.